Study S000400

Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol, Phase 3

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT00679042
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 21
Start: 2007-09-05
Primary completion: 2017-07-19
Lead sponsor: CellTrans Inc.
Conditions: Type 1 Diabetes Mellitus
Interventions: BIOLOGICAL:Islets of Langerhans transplantation
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Treatment Emergent Adverse Events [From first islet transplant through one year after last transplant (maximum 3 infusions possible), an average of 1 year]
Number of Subjects Reaching the Efficacy Goal [One year after islet transplant]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.